Treating Graves disease: drugs, radioiodine or surgery
- Follow-up and treatment
Graves disease has three good treatments. Choosing well means asking one question: wait for the immune attack to calm down, or remove the gland it is attacking?
See it in 3D: Thyroid gland · Parathyroid glands
What it is
Graves disease is autoimmune hyperthyroidism driven by antibodies that stimulate the TSH receptor (TRAb). It is treated with an antithyroid drug (methimazole or carbimazole; propylthiouracil in the first trimester, and either drug in storm), with radioiodine, or with total thyroidectomy. A beta-blocker controls symptoms while the chosen treatment takes effect. Drugs aim for remission and keep the gland; radioiodine and surgery are definitive and usually leave lifelong hypothyroidism, which is easy to replace.
What to know
- Methimazole (or carbimazole, which becomes methimazole) is the first-choice drug; propylthiouracil is kept for the first trimester (and is one option in thyroid storm) because of its rare but severe liver toxicity.
- A course of antithyroid drug lasts about 12–18 months; roughly half the patients relapse after stopping. Long-term low-dose methimazole is an accepted alternative to definitive treatment.
- Relapse is likelier with a large goitre, high TRAb at the end of treatment, severe disease, smoking and young age.
- Agranulocytosis is rare but can be fatal: every patient is told to stop the drug and get a blood count if fever or sore throat appear.
- Radioiodine is contraindicated in pregnancy and breastfeeding and in people planning pregnancy within about six months, and it can worsen thyroid eye disease, especially in smokers.
- Surgery is favoured for a large or compressive goitre, a suspicious nodule, coexisting hyperparathyroidism, moderate-to-severe eye disease or when radioiodine is not acceptable; the patient is made euthyroid first.
- After radioiodine or total thyroidectomy, levothyroxine is lifelong and TSH is checked for life.
The three treatments of Graves disease side by side
| Feature | Antithyroid drug | Radioiodine | Total thyroidectomy |
|---|---|---|---|
| Aim | Remission, keep the gland | Destroy the gland | Remove the gland |
| Speed | Weeks | Months | Immediate after surgery |
| Usual end state | Euthyroid in remission, or relapse | Hypothyroid on levothyroxine | Hypothyroid on levothyroxine |
| Main risks | Rash, agranulocytosis, liver injury | Worse eye disease; not in pregnancy | Hypocalcaemia, recurrent laryngeal nerve injury |
| Best for | Mild disease, small goitre, low TRAb, pregnancy | Relapse, older or cardiac patients, no active eye disease | Large goitre, nodule, eye disease, pregnancy wish soon |
In the clinic
- Baseline blood count and liver tests before starting an antithyroid drug make later changes interpretable.
- In older or cardiac patients, methimazole is often used first to make them euthyroid before radioiodine.
- Patients with mild active eye disease who choose radioiodine receive a glucocorticoid course to prevent worsening; those with moderate-to-severe active disease avoid radioiodine.
- Before surgery, iodine (potassium iodide) is often given for a few days to reduce the gland's blood flow.
Next step / Initial management
- Confirm the cause (TRAb or uptake scan), and measure blood count and liver tests before treatment.
- Start a beta-blocker for symptoms and methimazole for most patients; recheck free T4 and free T3 every 4–6 weeks, because TSH stays suppressed for months.
- Before stopping a drug course, measure TRAb: a high level predicts relapse and favours continuing or definitive treatment.
- Refer to endocrinology every new case, relapse, pregnancy or pregnancy plan, eye disease and drug toxicity; to surgery for compression or a suspicious nodule.
Common traps
- TSH guides the antithyroid drug in the first months: TSH stays suppressed long after free T4 normalises, so free T4 and free T3 guide early treatment.
- A sore throat with fever on methimazole is just a cold: it may be agranulocytosis, and the drug is stopped until a blood count is seen.
- Radioiodine is safe for a smoker with active eye disease: it can make the orbitopathy worse.
- Propylthiouracil is a fine choice at any stage: beyond the first trimester or storm, its liver toxicity outweighs any benefit.
- Hypothyroidism after radioiodine is a complication: it is the expected end point and is simply replaced.
Test yourself
Think of the answer, then tap the question to see it.
Why does a Graves patient have a suppressed TSH while the gland keeps working?
The stimulating antibody acts on the TSH receptor itself. High hormone switches off pituitary TSH, but the antibody keeps driving the gland, so feedback cannot stop it.
After 18 months of methimazole a patient still has high TRAb. What does it predict, and what are the options?
A high chance of relapse if the drug is stopped. Options are continuing low-dose methimazole long term, or definitive treatment with radioiodine or surgery.
Which Graves patient should not receive radioiodine, even though it is effective?
A pregnant or breastfeeding woman, someone planning pregnancy within months, and a patient with moderate-to-severe active eye disease, which radioiodine can worsen.
Six weeks into methimazole, free T4 is normal but TSH is still undetectable. Should you increase the drug?
No. TSH recovers slowly after months of suppression; free T4 and free T3 guide the dose early on. Increasing it would risk hypothyroidism.
Elsewhere in DurgiPedia
- Graves disease
- The thyroid axis: reading TSH and free T4
- Thyroid peroxidase (TPO)
- V/Q, bone and thyroid scans: when they are used
Connections
See it in 3D2
The structures of Durgical's 3D anatomy where it is found.
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Graves Disease (StatPearls (NCBI Bookshelf), 2023); Radioactive Iodine (I-131) Therapy for Hyperthyroidism and Thyroid Cancer (StatPearls (NCBI Bookshelf), 2026); Hyperthyroidism (StatPearls (NCBI Bookshelf), 2023); Thyroidectomy (StatPearls (NCBI Bookshelf), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
